StocksGuide Blog
Nov 26, 2025 | Levermann | Carsten Dreyer IDEXX Laboratories stock analysis – Hidden outperformer at all-time high – still a buy?
Sep 11, 2025 | Levermann | Carsten Dreyer AbbVie stock analysis: Top pharmaceutical stock at a fair price?
Feb 18, 2025 | Dividends | Carsten Dreyer ExxonMobil stock analysis: Record profits thanks to Trump's energy policy?
Jan 20, 2025 | Dividends | Carsten Dreyer Archer Daniels Midland stock analysis: Favourably rated dividend king or value trap?
Dec 12, 2024 | Dividends | Carsten Dreyer Snap-On Stock analysis: High dividend growth with franchise concept
Oct 30, 2024 | Dividends | Carsten Dreyer CVS Health stock analysis: Turnaround at last with a new CEO?
Sep 04, 2024 | Levermann | Carsten Dreyer Hermès Stock analysis: Premium luxury stock at a premium price
Register now for our free Insider
Subscribe now to the weekly StocksGuide Insider to make sure you don't miss anything. You will receive the latest stock analyses and product updates directly in your mailbox - completely free of charge and without obligation. Become a better investor with stocks.guide!
Subscribe now to the weekly StocksGuide Insider to make sure you don't miss anything. You will receive the latest stock analyses and product updates directly in your mailbox - completely free of charge and without obligation. Become a better investor with stocks.guide!